




MAGNESIUM SUPPLEMENTATION IN  
 














A thesis submitted to the faculty of 
The University of Utah 
















College of Health 












 Copyright © Brian Joseph Duke 2016 


















The thesis of Brian Joseph Duke 
has been approved by the following supervisory committee members: 
 
Thunder Jalili , Chair 5/26/16 
 Date Approved 
J. David Symons , Member 5/26/16 
 Date Approved 
Stacie Wing-Gaia , Member  
 Date Approved 
 
and by Julie Metos , Chair of  
the Department of Nutrition 
 

















 Magnesium (Mg) is an essential mineral that is important for bone health, energy 
production, and vasodilation; however, in the American diet, Mg intake is consistently 
below the Recommended Dietary Allowance (RDA). The aims of this project were to 1) 
assess which dietary form of Mg has the greatest bioavailability, 2) determine the effects 
of Mg depletion upon metabolic rate and energy expenditure, and 3) determine if Mg 
depletion alters vascular function. Sixty-four male C57BLK/6J mice were split into 4 
groups for tissue concentration studies. One group consumed a diet containing a 
concentration of 100mg/kg Mg Oxide (n=22) for 3 weeks to produce Mg depletion. The 
other groups followed the same 3 week Mg depletion protocol (100mg/kg Mg Oxide), but 
then were given either 500mg/kg Mg Citrate (n=10), 500mg/kg Mg Malate (n=10), or 
500mg/kg Mg Bisglycinate (n=22) for 1 week to replete Mg status. Mg Citrate and Mg 
Bisglycinate restored heart tissue Mg to equivalent concentrations while Mg Malate 
actually reduced heart Mg tissue concentration by 64% (p<.001). Mg Citrate restored 
bone Mg by 19% (p=.018), which was the greatest restoration. Liver Mg levels remained 
unchanged on all diets. Muscle Mg remained the same after replenishment with Mg 
Bisglycinate and was reduced by 62% on Mg Citrate (p<.001) and by 35% on Mg Malate 
(p<.001). A subset of 24 mice were used to address aims 2 and 3, and received 100mg/kg 
Mg Oxide diet for 3 weeks, or 100mg/kg Mg Oxide followed by repletion with 1 week on 
a 500mg/kg Mg Bisglycinate diet. Body fat was reduced by 35% in mice with 500mg/kg 
 iv 
 
Mg Bisglycinate (p=.005). Activity levels trended higher (p=.085), energy expenditure 
was higher (p=.001), and respiration rates were higher (p=.003) after repletion with 
500mg/kg Mg Bisglycinate. Function of the vasculature was unchanged after repletion 
with 500mg/kg Mg Bisglycinate. In conclusion, these results indicate that Mg Citrate and 
Mg Bisglycinate are more effective at restoring tissue mg levels than Mg Malate. Further, 
low Mg intake may induce unfavorable body composition changes and reduce energy 
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Magnesium (Mg) is an essential mineral that is important for bone health, energy 
production, and vasodilation (Bohl & Volpe, 2010). The typical American diet is high in 
refined foods and meat, which are low in Mg compared to diets rich in vegetables, whole 
grains, nuts, and seeds (Mahan & Escott-Stump, 2000), making it difficult to achieve 
recommended magnesium intakes. Multiple surveys, including the National Health and 
Nutrition Examination Survey III (NHANES III) (Cleveland, Goldman, & Borrud, 1994; 
Ford, 2003), and United States Department of Agriculture (USDA) Continuing Survey of 
Food Intake of Individuals II, have shown a median intake among the US population of 
326mg per day for men and 234mg per day for women (Cleveland et al., 1994), which is 
below the Estimated Average Requirement (EAR) of 350mg per day for men and 265mg 
per day for women. Nutritional recommendations that encourage the adequate intake of 
whole grains and fruits and vegetables with an emphasis on nut and seed consumption 
may, in time, lead to more adequate dietary intake of Mg. Until Americans follow these 
guidelines, supplement use can be an important source of Mg intake (Ford, 2003).  
Magnesium supplements come in different forms with varying bioavailability. 
Organic forms of Mg, such as citrate, aspartate, and fumarate, are better absorbed, 
utilized, and assimilated than the inorganic forms such as Mg oxide and hydroxide 
(Coudray, Rambeau, Feillet-Coudray, & Gueux, 2005; Fine, Ana, Porter, & Fordtran, 




rate of absorption and retention is a chelated form of Mg called Mg Bisglycinate 
(Schuette, Lashner, & Janghorbani, 1994; Siebrecht, 2013). Mg Bisglycinate is absorbed 
via the dipeptide transporter instead of competing with calcium for a mineral transport in 
the small intestine. Because it is chelated, it resists binding with phosphates, phytates, 
and tannins (Siebrecht, 2013). Specific details on how these supplemental forms of Mg 
replete various tissue concentrations following a period of low intake is needed to better 
assess the efficacy of each supplement. 
Mg is needed for the metabolism of carbohydrate, lipid, and protein (Bohl & Volpe, 
2010). Intracellular magnesium regulates insulin action and insulin-mediated glucose 
uptake, possibly by modulating phosphorylation and dephosphorylation events (Wolf & 
Trapani, 2008). Mg is needed for ATP production and utilization (Ko, Hong, & Pederson, 
1999).   Low Mg status may be related to decreased energy production, but there is a need 
to quantify the metabolic effects of low Mg status as it compares to a replete Mg status.     
Decreased Mg status may be related to cardiovascular disease, hypertension, type 
II diabetes, osteoporosis, muscle wasting, muscle weakness, and muscle cramps (Bohl & 
Volpe, 2010; Classen, 1984; Ford, 2003; Rosanoff, Weaver, & Rude, 2012). Mg plays a 
role in the regulation of blood pressure through its competition with calcium for calcium 
binding sites on the smooth muscle cells of the vasculature. Mg deficiency may also 
influence the enzymes in the signal transduction pathway involved in vascular constriction 
(Sontia, 2007). Mg stimulates prostacyclin production and nitric oxide (NO) formation in 
the endothelial cells, which modulate vasodilation in the vasculature (Yang, Gebrewold, & 
Nowakowski, 2000). Mg also inhibits norepinephrine release from nerve endings, which 




and anti-inflammatory actions of Mg could attenuate damage to the vasculature from 
reactive oxygen species, and aid in preventing hypertension (Sontia, 2007). Though Mg 
may have an important role in vasodilation and constriction, it is unclear what level of Mg 
depletion may be required before vascular function is compromised. 
The specific aims of this study were to 1) assess which dietary form of Mg has the 
greatest bioavailability by measuring liver, heart, muscle, and bone Mg concentration; 2) 
determine the effects of Mg depletion upon metabolic rate, energy expenditure, and 
concentration of metabolites in the liver; and 3) determine if Mg depletion alters vascular 
function.   
We hypothesized that 1) Mg Bisglycinate would replenish tissues better than Mg 
Citrate and Mg Malate; 2) after consuming low Mg, restoration of Mg with Mg 
Bisglycinate would increase metabolic rate, energy expenditure; and 3) Mg depletion 















MATERIALS AND METHODS 
 
 
Mice and groups with timeline 
All protocols used in the study were approved by the Animal Use and Care 
Committee at the University of Utah and conformed to guidelines set by the American 
Physiological Society and Animal Welfare Act. Sixty-four C57BL/6J male mice were 
obtained from The Jackson Laboratory Inc. (Bar Harbor, ME). Mice started diets at 8 
weeks old.  Mouse chow was obtained from Research Diets Inc. (New Brunswick, NJ).  
Mice were housed 4 or 5 to a cage on 12 hour light / 12 hour dark cycles. Deionized 
water was used for drinking water. Cages were changed daily to keep mice from 
ingesting their feces to prevent Mg recycling. Food and water was ad libitum. Mice were 
divided into the following experimental groups for this study. 
 Group 1 – N=22 (will be referred to as low Mg group). Mice underwent 3 weeks 
of magnesium restriction using a diet of 100mg/kg Mg Oxide (Carney, Wong, & 
Quamme, 1980; Feillet-Coudray, Coudray, & Wolf, 2004). Mg tissue content, body 
compostion, metabolic function, liver metabolite levels, and vessel reactivity were 
measured. 
 Group 2 – N=22 (will be referred to as restored Mg group). Mice underwent 3 
weeks of magnesium restriction using a diet of 100mg/kg Mg Oxide followed by 1 week 
of magnesium replenishment with a diet of 500mg/kg Mg Bisglycinate. Mg tissue 




reactivity were measured.  
 Group 3 – N=10. Mice underwent 3 weeks of magnesium restriction using a diet 
of 100mg/kg Mg Oxide followed by one week of replenishment using a diet of 500mg/kg 
Mg Citrate. Mg tissue content was measured. 
 Group 4 – N=10. Mice underwent 3 weeks of magnesium restriction using a diet 
of 100mg/kg Mg Oxide followed by one week of replenishment using a diet of 500mg/kg 
Mg Malate. Mg tissue content was measured. 
 
Euthanizing 
Mice were anesthetized using 3-5% isoflurane until the requisite plane of 
anesthesia was obtained. Next, the chest was opened. A blood sample via a cardiac 
puncture was obtained (750 ul-1000ul) and urine was collected via bladder puncture. The 
heart was then excised, and tissues obtained.  
 
Tissue analysis 
 Heart, liver, muscle (gastrocnemeus, soleus, and quadracep), and tibia bone were 
obtained after heart excision. Blood was centrifuged at 2500rpm for 15 minutes at 4°C 
and plasma was seperated by pipette. Tissues were dried and ashed at 500°C for 10 hours 
and the ash was dissolved in 0.2 mL of concentrated HNO3 and 9.2 mL of distilled water. 
For total Mg determination, samples were diluted appropriately with 0.1% lanthanum 
chloride and Mg level was determined by flame atomic absorption spectrometry (Perkin 







Nuclear magnetic resonance (NMR)  
 Fat mass, lean mass, and fluid mass were determined using NMR. Mice were 
individually weighed and placed inside chamber tube for measurements (Minispec 
Bruker Corp., Bellerica, MA). 
 
Metabolic chamber  
 The Columbus Instruments (Columbus, OH) Comprehensive Laboratory Mouse 
Monitoring System (CLAMS) metabolic chamber is an open circuit system that directly 
measures five parameters. Mice were housed singly with water and respective diets 
available ad libitum, and maintained at 20–22 °C under a 12:12-h light–dark cycle (light 
period 0600–1800 hours). Sample air was passed through an oxygen sensor for 
determination of oxygen content. Oxygen consumption was determined by measuring 
oxygen concentration in air entering the chamber compared with air leaving the chamber. 
The sensor was calibrated against a standard gas mix containing defined quantities of 
oxygen, carbon dioxide, and nitrogen. Constant airflow (0.6 l/min -1) was drawn through 
the chamber and monitored by a mass-sensitive flowmeter. The concentrations of oxygen 
and carbon dioxide were monitored at the inlet and outlet of the sealed chambers to 
calculate oxygen consumption. The system has beams 0.5 inches apart on the horizontal 
plane, providing a high-resolution grid covering the XY planes and the software provides 
counts of beam breaks by the mouse in 30-second intervals (Martin-Montalvo, Merken, 
& Mitchell, 2013). After allowing 18 hours for mice to acclimate to housing in the 
metabolic chamber, parameters of  1) oxygen consumption, 2) carbon dioxide production, 




continuous 48-hour period (see Figure 1). The University of Utah Metabolic Phenotyping 
Core performed these analyses. 
 
Glucose tolerance test (GTT) 
            Mice fasted for 6 hours in individual cages with water only. After body weights 
were recorded, glucose diluted in saline was injected at 1mg/g body weight 
intraperitoneally. Blood glucose levels were recorded from a nick at the tip of the tail at 
0, 5, 15, 30, 60, and 120 minutes.  
 
Metabolomics 
 Metabolomic analysis was performed at the Metabolomics Core Facility at the 
University of Utah.  Metabolites were identified based on known retention times and 
mass fragmentation patterns. The peak area for each metabolite was recorded, which can 
be used to compare groups in terms of relative abundance of each metabolite. The 
metabolites that were measured from liver samples were lactic acid, pyruvic acid, 
glycolic acid, glycerol, glyceric acid, citric acid, aconitate, isocitric acid, 2-ketoglutaric 
acid, succinic acid, fumaric acid, malic acid, 2-hydroxyglutarate, 2-aminoadipic acid, 
lysine, valine, leucine, isoleucine, threonine, homoserine, glycine, serine, alanine, 
glutamic acid, glutamine, proline, aspartic acid, asparagine, methionine, cysteine, 
homocysteine, phenylalanine, tyrosine, tryptophan, histidine, sarcosine, 4-
hydroxyproline, ornithine, N-acetylglutamate, N-acetylaspartate, B-alanine, phosphate, 
diphosphate, 1-phosphoglyceril, 2-phosphoglycerol, 3-phosphoglycerate, 2-
phosphoglycerate, phosphoenolpyruvate, fructose, mannose, ribose, glucose, glucose-1-




myo-inositol phosphate, sedoheptulose-7-P, sucrose, erythrose, erythose-4-phosphate, 
ribitolor xylitol, ribose(or xylose)-5-phosphate, ribulose(or xylose)-5-P, fucose, myristic 
acid, palmitiladic acid, 17:0 fatty acid, palmitic acid, linoleic acid, oleic acid, elaidic acid, 
stearic acid, 19:0 fatty acid, arachidonic acid, 20:1 fatty acid, 22:0 fatty acid, 24:0 fatty 
acid, 24:1 fatty acid, 1-monolinoleoylglycerol, 1-monooleoylglycerol, 1-
monostearylglycerol, 1-monopalmitoylglycerol, 2-monostearylglycerol, cholesterol, 
pantothenic acid, phosphoethanolamine, xanthine, hypoxanthine, adenosine, inosine, 
adenine, thymine, cytosine, uracil, adenosine-5’-monophosphate, inosine-5’-
monophosphate, kynurenine, tocopherol, 4-aminobutyrate, urea, creatinine, 3-
hydroxybutyrate, uric acid, serotonin, dopamine, 1,3-bisphosphoglycerate, 2-
hydroxybutyric acid, sucrose, nicotinamide, GSH reduced, 5-aminopentanoic acid, 2,3-
pyridinedicarboxylic acid, 5-hydroxytryptophan, porphobilinogen, and oleamide. 
 
Vessel experiments 
 Immediately following euthanizing, femoral arteries were isolated distal to the 
bifurcation of the internal iliac artery. Two vessel segments per mouse were treated 
identically and the results were averaged. During dissection, tissues were bathed in ice-
cold, oxygenated normal physiological saline solution (NPSS). Once isolated and free of 
adherent tissue, femoral arteries were mounted on a wire-type myograph while immersed 
in temperature-controlled, 8-ml tissue “bath” containing oxygenated (95% O2 -5% CO2) 
NPSS (pH 7.35 - 7.45). After the arteries were mounted, the tissue bath was gradually 
warmed to 37°C over 30 minutes with vessels at 0-mg tension. During this time and 
throughout each experiment, the pH and temperature of all buffer solutions were checked 





 When the tissue bath reached 37°C, tension on femoral arteries was increased 
manually over 60 minutes to 2g. After 30 minutes, a series of internal circumference-
active tension curves was constructed to determine the vessel diameter that evoked the 
greatest tension development to 100mM KCL. Receptor-mediated vasocontractile 
responses to phenylephrine (PE 10-8 – 10-5 M) and potassium chloride (KCL, 10-100mM) 
were assessed 30 minutes later. Next, after arteries were precontracted to 65% of 
maximal PE induced contraction and tension was stable, responses to acetylcholine (Ach, 
10-8 – 10-4 M; to determine endothelium dependent vasorelaxation), and sodium 
nitroprusside (SNP, 10-9 – 10-4 M; to determine endothelium independent vasorelaxation) 
were performed. Each protocol was separated by at least 30 minutes. All tension data 
were recorded continuously by a computer through an analog-to-digital interface card 
(Biopac Systems Inc., Santa Barbara, CA) that allowed for subsequent off-line 
quantitative analyses (Symons, McMillin, & Riehle, 2008).  
 
Statistics 
 Statistics were done using SPSS version 20 with an accepted significance level of 
p<.05. Data are presented as a mean +/- standard error (SE). An unpaired t-test was used 
for NMR, GTT, and to compare each cycle (light and dark) between the low vs. restored 
groups in the metabolic chamber (CLAMS). For these analyses, significance is denoted in 
the figures by an asteriks (*). A one-way ANOVA was used to test Mg tissue 
concentration. For these analyses, significance is denoted in the figures by using letters 
such that different letters denote significant differences among groups. An ANOVA with 





























Tissue analysis  
 Group 1-4 mice were tested for Mg concentration in liver, heart, muscle (gastroc, 
soleus, quadracep), and tibia bone tissues. No significant differences were found in liver 
tissue Mg concentration (see Figure 2a). Compared to mice fed low Mg diet (100 mg/kg 
chow Mg Oxide), mice fed a repenishment diet of 500 mg/kg Mg Citrate and 500 mg/kg 
Mg Bisglycinate had significantly greater Mg concentration in the heart than mice fed a 
replenishment diet of 500 mg/kg Mg Malate (see Figure 2b). In muscle tissue, there was 
no difference in Mg concentration between the 100 mg/kg Mg Oxide diet and the 500 
mg/kg Mg Bisglycinate diet; however, both of these were greater than the 500 mg/kg Mg 
Malate and 500 mg/kg Mg Citrate diets (see Figure 2c). Compared to mice fed low Mg 
diet, bone Mg concentrations were greater after replenishment with 500 mg/kg Mg 
Citrate compared to all groups (see Figure 2d), and there was a trend toward lower Mg 
bone concentrations after replenishment with 500 mg/kg Mg Malate vs. 100 mg/kg Mg 
Oxide (p=.051) (see Figure 2d). Replenishment using 500 mg/kg Mg Bisglycinate partly 
increased bone Mg content such that concentrations were in between levels found in mice 
fed 100 mg/kg Mg Oxide diets and mice replenished with 500 mg/kg Mg Citrate, and 








 Final body weight and composition  
   
 Final body weight, fat mass, percent body fat, lean body mass, percent lean body 
mass, fluid mass, and percent fluid mass were determined. The restored Mg group had 
significantly less fat mass and percent body fat than the low Mg group. A significant 
difference was also found in the percent fluid mass measurement, with the restored Mg 
group having a higher percent fluid mass than the low Mg group (p<.001) (see Figures 
3a-g).  
 
Metabolic chamber  
  The restored Mg group had significantly more beam brakens in the Y plane 
during the inactive light cycle at the p<.05 level.  There was a trend toward the restored 
Mg group having more beam brakes in the X plane during the active dark cycle, in the Y 
plane during the active dark cycle, and in total beam brakes in a 48-hour period (p≤.10) 
(see Figure 4a-d). Taken together, these data indicate increased physical activity 
(movement) in mice while on the restored Mg diet.  
 
Metabolic rate and gas exchange 
 Gas exchange of VO2 and VCO2 was measured in the metabolic cages.  A 
significant increase in VO2 respired and VCO2 expired was seen in the restored Mg 
group relavite to the low Mg group (p<.05) (see Figure 5a,b). 
 
Respiratory exchange ratio (RER), food and water intake, 
energy expenditure 
No significant differences were noted in RER, food, or water intake between 




measure in the metabolic cages in Kcal per hour.  The low Mg group had less energy 
expenditure than the restored Mg group (p<.05) (see Figure 6). 
 
Glucose tolerance test (GTT) 
 Tolerance to a glucose challenge was measured.  Glucose levels at baseline and at 
each time point up to 2 hours after intraperitoneal glucose challenge were similar 
between low Mg and restored Mg groups (see Figure 7).  
 
Metabolomics  
 In analysing mice liver tissue, significant differences were found in the levels of 
glycine, inosine, and reduced glutathione, with each of these metabolites being in higher 
quantities in the restored Mg group when compared to the low Mg group. The fatty acid 
22:0 had a higher quantity in the low Mg group compared to the restored Mg group. 
None of the other metabolites measured had significant differences (see Table 2). 
 
Vessel function testing  
 
 Femoral artery vessels showed no significant difference in start width, end width, 
vessel length, and maximum tension force (see Table 3).  
Femoral artery vessels showed no significant difference in endothelium dependent 
or endothelial independent function between low Mg and restored Mg groups when 
challenged with acetylcholine, sodium nitroprusside, phenylephrine, and potassium 
chloride. Vessel response to acetylcholine, an endothelium dependent and receptor 
dependent arterial vasodilator, was similar among groups (see Figure 8a).  Vessel dilation 
in response to sodium nitroprusside, an endothelium independent and receptor 




phenylephrine, a receptor dependent vasoconstrictor, was not different among groups (see 
Figure 8c), as was contraction response to potassium chloride, a receptor independent 































Figure 2 Liver, heart, muscle, and bone tissue concentrations of Mg. Different letters 
signify significant differences at p<.05.  a) Liver. All groups had n=10.  b) Heart. 
100MgOx n=11, 500MgMalate and 500MgCitrate n=10, 500MgBisGly n=9. c)  Muscle. 
100MgOx n=11, 500MgMalate and 500MgCitrate n=10, 500MgBisGly n=7. d) Bone. 
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Figure 3 Results of body composition analysis. Asterisks * denote significant differences; 
p<.05. Low Mg group n=10, restored Mg group n=7.  a) Final body weight. b) Fat mass. 
c) Percent body fat. d) Lean body mass. e) Percent lean body mass. f) Fluid mass. g) 
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Figure 4 Physical activity parameters. Reported as beam breaks in the X, Y, and Z plane. 
Low Mg group n=11, restored Mg group n=12. Asterisk * denotes significant differences; 
p<.05. a) X plane movement. b) Y plane movement. c) Z plane movement.  d) 48-hour 
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Figure 5 Gasses exchanged in metabolic cages.  Low Mg group n=11, restored Mg group 
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Table 1 RER, food, and water intake (combined over two cycles) in grams.  
Low Mg group n=11, restored Mg group n=12 
 
_______________________________________________________________________ 
Low Mg         Restored Mg        Low Mg         Restored Mg 
                    Active Cycle      Active Cycle        Rest Cycle       Rest Cycle 
_______________________________________________________________________ 
RER  .961 +/- .013   .969 +/- .014    .952 +/- .013      .979 +/- .014 
Food Intake   4.325 +/- .271     4.38 +/- .283    3.584 +/- .271   4.1575 +/- .283 






Figure 6 Energy expended reported in kcal/hour. Low Mg group n=11, restored Mg 
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Figure 7 Glucose tolerance tests (GTT) results. Reported as measured blood glucose level 
in mg/dL. Low Mg group n=11, restored Mg group n=12. Asterisks * denote significant 





Table 2 Hepatic analysis of metabolites with significant differences.   
Data expressed as mean +/- SE in units of relative abundance.  
Low Mg group n=7, restored Mg group n=7 
_______________________________________________________________________ 
             Metabolite  Low Mg       Restored Mg                 P value 
_______________________________________________________________________ 
               Glycine       1401.3 +/- 68.9      1906.1 +/- 163.24             .015 
        22:0 Fatty acid            10.23 +/- 1.1                4.22 +/- 1.34                 .005 
               Inosine                 54.05 +/- 12.6           152.06 +/- 39.58              .036 



































Table 3 Vessel characteristics. No significance between groups.  
Values are presented as mean +/- SE. 
Low Mg group n=9, restored Mg group n=10 
_______________________________________________________________________ 
                         Start Width        End Width      Vessel Length       Max Tension Force 
         (µm)         (µm)           (µm)    (mg tension)        
_______________________________________________________________________ 
Low Mg  172.6 +/- 7.7     477.8 +/- 5.3    1832.2 +/- 29.7      2537.89 +/- 112.3 





Figure 8 Results of vessel functions tests. Low Mg n=9, Restored Mg n=10 a) 
Endothelial and receptor dependent arterial relaxation. b) Endothelial and receptor 
independent arterial relaxation. c) Receptor dependent arterial contraction. d) Receptor 























































































































Summary of main findings 
 Mg Citrate and Mg Bisglycinate restored bone and heart Mg tissue levels in a 
mouse model better than Mg Malate. After 3 weeks on low Mg diets, mice had 
significantly greater body fat and reduced energy expenditure compared to mice that were 
switched to restored Mg diets. These differences can likely be attributed to increased 
activity levels in the restored Mg group vs. the low Mg group. In liver tissue, reduced 
glutathione, inosine, and glycine were higher in the restored Mg group, while 22:0 fatty 
acid was higher in the low Mg group.  
 
Mg absorption  
 Brilla, Frederickson, and Lombardi (1989) reported that the skeletal muscle Mg 
concentration is protected at the expense of bone Mg and other slowly exchanging pools 
of magnesium.  The results from the muscle magnesium concentration test support this 
finding as the muscle Mg was maintained at the same level between the 100 mg/kg Mg 
Oxide groups and  the 500 mg/kg Mg Bisglycinate group, while the bone Mg was lower 
in the 100 mg/kg Mg Oxide group than in the 500 mg/kg Mg Citrate group.  A limitation 
of our analysis, however, is that due to limitations on tissue amounts, gastrocnemius, 
soleus, and quadracep were pooled together for analysis. It is possible that each tissue 
may have different Mg profiles, thus leading to variability in these results.  




brain may lose small but significant amounts of magnesium while the liver appears not to 
lose magnesium.  The results of the present study support these assertions as the liver Mg 
concentration was the same across all groups, while in the heart, the 100 mg/kg Mg 
Oxide group had significantly less Mg than the 500 mg/kg Mg Citrate or 500 mg/kg Mg 
Bisglycinate groups. The 500 mg/kg Mg Malate group had the lowest amount of heart 
and bone Mg and appears to deplete or fail to restore Mg. It has been known for over 30 
years that those who die of heart disease have lower heart Mg than those who die from 
other causes (Elwood & Beasley, 1981). These results underscore the need for a continual 
optimum intake of Mg to maintain critical tissue levels.    
 
Body composition 
 The higher fat mass and fat percentage seen in the low Mg group was likely the 
result of reduced activity. To our knowledge, this is the first study to report changes in 
energy expenditure and body composition in mice with low Mg diets. We saw higher 
activity in the restored Mg group during CLAMS testing as well as a higher energy 
expenditure and a higher rate of respiration. Few studies have assessed voluntary activity; 
however, Keen, Lowney, Gershwin, Hurely, and Stern (1987) reported that Mg depleted 
rats had reduced exercise endurance capacity 
 
Metabolic chamber and metabolomics 
 Food intake was the same between the low Mg group and the restored Mg group, 
indicating the only difference in nutrient intakes was the Mg intake. The lack of 
difference in the glucose tolerance test between low Mg and restored Mg treatments 




normal cellular glucose uptake. This is also in contrast to previous studies that suggest 
low Mg status is correlated with insulin resistance and diabetes (Rosanoff et al., 2012). 
Perhaps more severe Mg depletion is required to impair glucose tolerance. Finally, the 
glucose tolerance in this study was in line with the measured Respiratory Exchange Ratio 
(RER) that indicated similar macronutrient utilization between groups. Taken together, 
these data suggest that carbohydrate uptake and utilization is not altered by this dietary 
approach. 
 The greater levels of reduced glutathione in the restored Mg group vs. the low Mg 
group (metabolomics data) indicate an inhibition of the two Mg-dependent enzymes 
needed to synthesize glutathione, glutamyl cysteine synthetase, and glutathione 
synthetase. This finding supports similar results seen in an earlier study (Regan & Guo, 
2001).  Synthesis of glycine is not directly Mg dependent, though glycine is one of the 
three amino acids making up reduced glutathione. The reduction in glutathione could be 
in part due to the lower concentrations of glycine seen.  Lack of significance for the 
majority of the metabolites in the metabolomics results is likely influenced by the lack of 
difference in liver tissue magnesium seen in the tissue analysis results.  
 
Vascular function 
 In spite of following a low dietary Mg protocol that reduced heart Mg 
concentations and has been previously reported to compromise Mg status in mice 
(Feillet-Coudray et al., 2004), we found no changes in arterial function. A potential 
confounder of the vessel reactivity experiments was the presence of Mg in the buffers 
used to keep the vessels functional during the experiments. Plasma Mg levels in rats have 




similar period of time as in the present study (Keen et al., 1987).   Mg is known to enter 
the vascular smooth muscle cells when present extracellularly and, when present at levels 
of 4.8 mmol, can more than double the intracellular concentration of Mg in only 5 
minutes (Zhang, Chang, Altura, & Altura, 1992). In the present study, vessels were 
incubated in buffer containing 1 mmol Mg for 3-6 hours during the vessel experiments.  
Altura and Altura (1990) indicated that extracellular Mg can effect the tone and 
contractility of the vascular smooth muscle cells by altering the intracellular binding and 
transport of calcium. 
 
Conclusion 
 The results of the present study show a need for continuous optimal intake of Mg 
in order to maintain tissue levels of magnesium, and we found that in general, tissue Mg 
levels are protected in liver and muscle. Mg Citrate and Mg Bisglycinate restored bone 
and heart Mg levels better than Mg Malate, suggesting greater bioavailability of these 
isoforms. The lower activity level seen in the low Mg group relative to the restored Mg 
group was a striking finding, and appears to explain the increased body fat in these mice. 
However, it is unknown why Mg depletion reduces voluntary physical activity; therefore, 
this phenomenon warrants further exploration as to the mechanistic cause. Finally, the 
impact that dietary Mg had on body fat in this study may have clinical relevance when 
one considers the current epidemic of obesity in the United States. Future studies should 
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